Dexamethasone Sodium Phosphate
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Medical Purchasing Solutions, LLC | repackager | 2 | SUPPLYING |
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 2 | SUPPLYING |
| Eugia US LLC | generic | 2 | SUPPLYING |
| A-S Medication Solutions | repackager | 1 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
| Civica, Inc | unknown | 1 | SUPPLYING |
| Cardinal Health 107, LLC | repackager | 1 | SUPPLYING |
| Somerset Therapeutics, LLC | generic | 1 | SUPPLYING |
| ADVANCED RX PHARMACY OF TENNESSEE, LLC | repackager | 1 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | generic | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Dexamethasone Sodium Phosphate Injection — reported in shortage by Eugia US LLC. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology.
Dexamethasone Sodium Phosphate Injection — reported in shortage by Somerset Therapeutics, LLC. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology.
